Compare GRFS & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | SNEX |
|---|---|---|
| Founded | 1940 | 1924 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.9B |
| IPO Year | 2006 | 1994 |
| Metric | GRFS | SNEX |
|---|---|---|
| Price | $9.02 | $98.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $10.15 | N/A |
| AVG Volume (30 Days) | ★ 551.2K | 393.3K |
| Earning Date | 01-01-0001 | 02-04-2026 |
| Dividend Yield | ★ 1.58% | N/A |
| EPS Growth | N/A | ★ 10.92 |
| EPS | 0.64 | ★ 5.89 |
| Revenue | $8,821,017,248.00 | ★ $130,897,700,000.00 |
| Revenue This Year | $5.36 | N/A |
| Revenue Next Year | $5.15 | $5.74 |
| P/E Ratio | $17.99 | ★ $16.65 |
| Revenue Growth | 7.31 | ★ 32.62 |
| 52 Week Low | $6.19 | $63.64 |
| 52 Week High | $11.14 | $106.98 |
| Indicator | GRFS | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 53.16 | 59.43 |
| Support Level | $8.69 | $95.36 |
| Resistance Level | $9.22 | $99.10 |
| Average True Range (ATR) | 0.18 | 2.98 |
| MACD | 0.03 | 0.30 |
| Stochastic Oscillator | 64.15 | 71.43 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.